These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 6348805

  • 1. Reduced urinary excretion of prostaglandin E in essential hypertension.
    Sato K, Abe K, Seino M, Yasujima M, Chiba S, Sato M, Haruyama T, Hiwatari M, Goto T, Tajima J, Tanno M, Yoshinaga K.
    Prostaglandins Leukot Med; 1983 Jun; 11(2):189-97. PubMed ID: 6348805
    [Abstract] [Full Text] [Related]

  • 2. Impaired renal prostaglandin E2 biosynthesis in human hypertensive states.
    Tan SY, Bravo E, Mulrow PJ.
    Prostaglandins Med; 1978 Jul; 1(1):76-85. PubMed ID: 213795
    [Abstract] [Full Text] [Related]

  • 3. Implication of renal prostaglandin E in urinary sodium excretion.
    Yasujima M, Abe K, Chiba S, Sato M, Irokawa N, Seino M, Imai Y, Saito K, Sakurai Y, Ito T, Haruyama T, Ritsu K, Yoshinaga K.
    Jpn Circ J; 1978 May; 42(5):565-9. PubMed ID: 702774
    [Abstract] [Full Text] [Related]

  • 4. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K, Yasujima M, Chiba S, Sato M, Irokawa N, Imai Y, Yoshinaga K.
    Adv Exp Med Biol; 1979 May; 120B():487-501. PubMed ID: 517244
    [Abstract] [Full Text] [Related]

  • 5. [Urinary excretion of prostaglandin E in various female hypertensive diseases--with special reference to ages, urinary excretion of electrolytes and the severity of hypertension].
    Sato K, Abe K, Yoshinaga K.
    Nihon Jinzo Gakkai Shi; 1983 Nov; 25(11):1367-74. PubMed ID: 6674650
    [No Abstract] [Full Text] [Related]

  • 6. Prostaglandin excretion after furosemide in normal and low-renin essential hypertension.
    Scherer B, Witzgall H, Weber PC.
    Klin Wochenschr; 1984 Aug 16; 62(16):777-82. PubMed ID: 6384651
    [Abstract] [Full Text] [Related]

  • 7. Prostaglandin E synthesis in the kidney in renin subgroups of essential hypertension.
    Sato K, Abe K, Sato M, Haruyama T, Yasujima M, Hiwatari M, Tajima J, Kasai Y, Chiba S, Seino M, Yoshinaga K.
    Prostaglandins Leukot Med; 1982 Nov 16; 9(5):577-85. PubMed ID: 6757970
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL, Zeng ZP, Tong AL, Lu L, Chen S, Li M, Fu CL, Wang YH, Sun ML.
    Zhonghua Nei Ke Za Zhi; 2012 Apr 16; 51(4):294-8. PubMed ID: 22781950
    [Abstract] [Full Text] [Related]

  • 11. Effect of spironolactone on urinary excretion of immunoreactive prostaglandin E in essential hypertension and primary aldosteronism.
    Chiba S, Abe K, Yasujima M, Irokawa N, Seino M, Sakurai Y, Sato M, Otsuka Y, Yoshinaga K.
    Tohoku J Exp Med; 1978 Apr 16; 124(4):297-305. PubMed ID: 663929
    [Abstract] [Full Text] [Related]

  • 12. [The significance of atrial natriuretic polypeptide in the cause of essential hypertension].
    Mori K.
    Nihon Naibunpi Gakkai Zasshi; 1991 Jul 20; 67(7):796-810. PubMed ID: 1653713
    [Abstract] [Full Text] [Related]

  • 13. [Studies on abnormalities of adrenal steroidogenesis in essential hypertension, primary aldosteronism and renovascular hypertension: responses of plasma steroids to angiotensin III].
    Itoh N.
    Nihon Naibunpi Gakkai Zasshi; 1988 May 20; 64(5):419-38. PubMed ID: 3410145
    [Abstract] [Full Text] [Related]

  • 14. Effects of orally administered glandular kallikrein on urinary kallikrein and prostaglandin excretion, plasma immunoreactive prostanoids and platelet aggregation in essential hypertension.
    Ogawa K, Ito T, Ban M, Mochizuki M, Satake T.
    Klin Wochenschr; 1985 Apr 01; 63(7):332-6. PubMed ID: 3889484
    [Abstract] [Full Text] [Related]

  • 15. Effect of triamterene on urinary excretion of immunoreactive prostaglandin E in essential hypertension.
    Chiba S, Abe K, Yasujima M, Irokawa N, Saito K, Sakurai Y, Ito T, Sato M, Otsuka Y, Yoshinaga K.
    Tohoku J Exp Med; 1979 Nov 01; 129(3):249-56. PubMed ID: 524352
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
    Chen S, Zeng ZP, Song AL, Zhu L, Lu L, Tong AL, Shi C, Li HZ.
    Zhonghua Nei Ke Za Zhi; 2017 Jun 01; 56(6):402-408. PubMed ID: 28592038
    [Abstract] [Full Text] [Related]

  • 19. High urine flow rate increase prostaglandin E excretion in the conscious dog.
    Wright LF, Rosenblatt SG, Lifschitz MD.
    Prostaglandins; 1981 Jul 01; 22(1):21-34. PubMed ID: 6794099
    [Abstract] [Full Text] [Related]

  • 20. [Urinary kallikrein and prostaglandin E2 excretion before and after operation in adrenal and renal hypertensive patients].
    Nigawara K, Yagihashi Y, Hitomi H, Kogawa T, Suzuki T, Funyu T, Terayama Y, Yamaya K, Igarashi R.
    Nihon Jinzo Gakkai Shi; 1986 Apr 01; 28(4):469-80. PubMed ID: 3462401
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.